Variant report
Variant | esv3400295 |
---|---|
Chromosome Location | chr4:165875177-165875495 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:165874581..165877460-chr4:165878651..165880772,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192530768 | chr4:165875177-165875178 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76852934 | chr4:165875183-165875184 | Flanking Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542503774 | chr4:165875237-165875238 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567915507 | chr4:165875261-165875262 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200209485 | chr4:165875276-165875277 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557791878 | chr4:165875302-165875303 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572722811 | chr4:165875312-165875313 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533904874 | chr4:165875352-165875353 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139794503 | chr4:165875358-165875359 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28544252 | chr4:165875359-165875360 | Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs543992669 | chr4:165875375-165875376 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149369015 | chr4:165875376-165875377 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144719802 | chr4:165875379-165875380 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544874199 | chr4:165875407-165875408 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530740168 | chr4:165875426-165875427 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558825580 | chr4:165875444-165875445 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560548564 | chr4:165875450-165875451 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575693009 | chr4:165875451-165875452 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114249943 | chr4:165875457-165875458 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184518745 | chr4:165875474-165875475 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:165871000-165877800 | Weak transcription | Spleen | Spleen |
2 | chr4:165871200-165877600 | Weak transcription | GM12878-XiMat | blood |
3 | chr4:165874000-165877800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr4:165874000-165878000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr4:165874200-165877800 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
6 | chr4:165874800-165875200 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:165875000-165875200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr4:165875000-165875400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr4:165875000-165875600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr4:165875200-165875600 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
11 | chr4:165875400-165877600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |